chr12-26956572-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015633.3(FGFR1OP2):āc.165A>Cā(p.Glu55Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000257 in 1,590,012 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015633.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FGFR1OP2 | NM_015633.3 | c.165A>C | p.Glu55Asp | missense_variant | 3/7 | ENST00000229395.8 | |
FGFR1OP2 | NM_001171887.2 | c.165A>C | p.Glu55Asp | missense_variant | 3/6 | ||
FGFR1OP2 | NM_001171888.2 | c.165A>C | p.Glu55Asp | missense_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FGFR1OP2 | ENST00000229395.8 | c.165A>C | p.Glu55Asp | missense_variant | 3/7 | 2 | NM_015633.3 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 151456Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000985 AC: 24AN: 243556Hom.: 0 AF XY: 0.000106 AC XY: 14AN XY: 132166
GnomAD4 exome AF: 0.000271 AC: 390AN: 1438556Hom.: 0 Cov.: 29 AF XY: 0.000257 AC XY: 184AN XY: 716286
GnomAD4 genome AF: 0.000125 AC: 19AN: 151456Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 8AN XY: 73976
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 19, 2022 | The c.165A>C (p.E55D) alteration is located in exon 3 (coding exon 2) of the FGFR1OP2 gene. This alteration results from a A to C substitution at nucleotide position 165, causing the glutamic acid (E) at amino acid position 55 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at